Rongchang Biotech (09995): Antibody-drug conjugate RC278 receives notice of drug clinical trial application acceptance.

Wisdom Finance and Economics APP News, Rongchang Biotechnology (09995) announced that recently, the company received the "Acceptance Notice" issued by the National Medical Products Administration for the clinical trial application of the new antibody-drug conjugate (ADC) drug injection RC278.